Two hemophilia patients in the U.S. who struggled for years with bleeds have been given Hemgenix, the first gene therapy ...
Columnist G Shellye Horowitz wasn't surprised to learn she had osteopenia, as her bleeding disorder increases her risk of low ...
The U.S. FDA has approved Alhemo, given as once-daily injections, to help prevent bleeds in patients with hemophilia A or B ...
Sangamo will regain full rights to giroctocogene fitelparvovec, a gene therapy candidate for hemophilia A, after Pfizer ended ...
Columnist Jennifer Lynne reflects on her most-read columns from last year and why those stories resonated with the hemophilia community.
On Monday, my youngest son, Caeleb, will begin his second semester as a freshman at the University of New Mexico. Last night he asked me if I had a few minutes to talk. I might not be the sharpest ...
MacDonald worries about her adult son being complacent when it comes to administering his hemophilia medication.
Columnist Alliah Czarielle says a conversation she had with her husband about manual wheelchairs surprised her.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback